TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2020

Pharmacokinetic Similarity and Comparative Pharmacodynamics, Safety, Efficacy, and Immunogenicity of DRL_RI Versus Reference Rituximab in Biologics-Naïve Patients with Moderate-to-Severe Rheumatoid Arthritis: A Double-Blind, Randomized, Three-Arm Study.

Vikram Muralidhar Haridas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.